PC
ISEE

Pier Capital’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

Pier Capital’s Portfolio ISEE Stock Details ISEE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-231,162
Closed -$5.62M – 129
2023
Q1 		$5.62M Buy
231,162
+2,410
+1% +$52.8K 0.85% 65
2022
Q4 		$4.9M Sell
228,752
-3,230
-1% -$68.9K 0.8% 63
2022
Q3 		$4.16M Sell
231,982
-110,905
-32% -$1.46M 0.72% 72
2022
Q2 		$3.3M Sell
342,887
-213,954
-38% -$2.69M 0.56% 79
2022
Q1 		$9.37M Buy
556,841
+128,387
+30% +$1.9M 1.2% 32
2021
Q4 		$7.16M Buy
+428,454
New +$7.02M 0.76% 73
2016
Q3 		– Sell
-110,679
Closed -$5.65M – 141
2016
Q2 		$5.65M Buy
+110,679
New +$5.5M 1.03% 37
2014
Q1 		– Sell
-107,355
Closed -$3.47M – 163
2013
Q4 		$3.47M Buy
+107,355
New +$3.19M 0.46% 94

Other funds holding ISEE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return
BCM
Beryl Capital Management Redondo Beach, California $110M AUM 317.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
TAL
TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return

Pier Capital's ISEE Position: Q2 2023 in Review

Pier Capital sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q2 2023, closing a stake of 231,162 shares — an estimated $5.62M sold.

Pier Capital first reported a position in ISEE in Q4 2013 and held it in 8 quarters. The position peaked at $9.37M in Q1 2022. 256 funds tracked by Wall St. Rank hold ISEE as of Q2 2023.

  • Pier Capital reported no remaining IVERIC bio, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
  • Pier Capital sold 231,162 IVERIC bio, Inc. Common Stock shares in Q2 2023, an estimated $5.62M.
  • Pier Capital first reported a position in IVERIC bio, Inc. Common Stock in Q4 2013 and held it in 8 quarters.
  • Pier Capital's IVERIC bio, Inc. Common Stock position peaked at $9.37M in Q1 2022.
  • 256 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q2 2023.

Based on Pier Capital's 13F filing for Q2 2023, filed 14 Aug 2023.